TrialInternational journal of hematology2017

Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study.

Dai Maruyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.